Logo

UK s CSC/Imperial College Microarray Center to Use Rosetta Resolver

Mar 07, 2005

NEW YORK, March 7 (GenomeWeb News) - Rosetta Biosoftware said today that the MRC Clinical Sciences Center and Imperial College London have jointly licensed the Rosetta Resolver gene expression analysis platform for use in the CSC/Imperial College Microarray Center.

 

The research institutes, both based in London, licensed the system with funding from the UK's Medical Research Council and the British Heart Foundation.

 

Financial terms of the licensing agreement were not disclosed.

 

Last week, Rosetta announced that it had licensed the Resolver software to Serono.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.